Procurement Summary
Country: USA
Summary: Advanced Development Of Informatics Technologies For Cancer Research And Management (U24 Clinical Trial Optional)
Deadline: 19 Oct 2026
Posting Date: 22 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141809896
Document Ref. No.: RFA-CA-27-020
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
72222000 - Information systems or technology strategic review and planning services
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
This Notice Of Funding Opportunity (Nofo) Invites Applications For Advanced Development And Enhancement Of Emerging Informatics Technologies To Improve The Acquisition, Analysis, Visualization, And Interpretation Of Data Across The Cancer Research Continuum Including Cancer Biology, Cancer Treatment And Diagnosis, Early Cancer Detection, Risk Assessment And Prevention, Cancer Control And Epidemiology. As A Component Of The Nci'S Informatics Technology For Cancer Research (Itcr) Program, This Nofo Is Focused On Advancing Emerging Informatics Technology, Defined As One That Has Passed The Initial... Prototyping And Pilot Development Stage, Has Demonstrated Potential To Have A Significant And Broader Impact, Has Compelling Reasons For Further Improvement And Enhancement, And Has Not Been Widely Adopted In The Cancer Research Field. To Be Successful, Proposed Development Plans Must Have A Clear Rationale For Why The Proposed Technology Is Needed And How It Will Benefit The Cancer Research Field. In Addition, Mechanisms To Solicit Feedback From Driving Cancer Research Projects As Well As The Broader User Community Throughout The Development Process Must Be Included.This Nofo Invites Applications For The Enhancement And Dissemination Of Emerging, User-Friendly Informatics Technologies That Support A Wide Range Of Cancer Research, Including Discovery Biology, Population Studies, As Well As Clinical And Translational Research. The Emphasis Is On Uniqueness And Potential Impact On Can...
Award min: $50, 000
Award max: $600, 000
Posted Date: 2026-05-21 00:00:00
Funding instrument type: Cooperative agreement
Documents
Tender Notice